116 related articles for article (PubMed ID: 38354830)
1. MiRNA Signatures Related to Invasiveness and Recurrence in Patients With Non-Functioning Pituitary Neuroendocrine Tumors.
Nikolova E; Nankova A; Kalenderova S; Georgieva B; Hadzhiyanev A; Bichev S; Savov A; Todorova A; Mitev V; Elenkova A
Exp Clin Endocrinol Diabetes; 2024 May; 132(5):240-248. PubMed ID: 38354830
[TBL] [Abstract][Full Text] [Related]
2. Novel Biomarkers for Non-functioning Invasive Pituitary Adenomas were Identified by Using Analysis of microRNAs Expression Profile.
Wu S; Gu Y; Huang Y; Wong TC; Ding H; Liu T; Zhang Y; Zhang X
Biochem Genet; 2017 Jun; 55(3):253-267. PubMed ID: 28315020
[TBL] [Abstract][Full Text] [Related]
3. MicroRNAs expression in pituitary tumors: differences related to functional status, pathological features, and clinical behavior.
Vicchio TM; Aliquò F; Ruggeri RM; Ragonese M; Giuffrida G; Cotta OR; Spagnolo F; Torre ML; Alibrandi A; Asmundo A; Angileri FF; Esposito F; Polito F; Oteri R; Aguennouz MH; Cannavò S; Ferraù F
J Endocrinol Invest; 2020 Jul; 43(7):947-958. PubMed ID: 31939196
[TBL] [Abstract][Full Text] [Related]
4. Analysis of Deregulated microRNAs and Their Target Genes in Gastric Cancer.
Juzėnas S; Saltenienė V; Kupcinskas J; Link A; Kiudelis G; Jonaitis L; Jarmalaite S; Kupcinskas L; Malfertheiner P; Skieceviciene J
PLoS One; 2015; 10(7):e0132327. PubMed ID: 26172537
[TBL] [Abstract][Full Text] [Related]
5. Differentially Expressed miRNAs Influence Metabolic Processes in Pituitary Oncocytoma.
Krokker L; Nyírő G; Reiniger L; Darvasi O; Szücs N; Czirják S; Tóth M; Igaz P; Patócs A; Butz H
Neurochem Res; 2019 Oct; 44(10):2360-2371. PubMed ID: 30945144
[TBL] [Abstract][Full Text] [Related]
6. MiR-132, miR-15a and miR-16 synergistically inhibit pituitary tumor cell proliferation, invasion and migration by targeting Sox5.
Renjie W; Haiqian L
Cancer Lett; 2015 Jan; 356(2 Pt B):568-78. PubMed ID: 25305447
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA involvement in a metastatic non-functioning pituitary carcinoma.
Wei Z; Zhou C; Liu M; Yao Y; Sun J; Xiao J; Ma W; Zhu H; Wang R
Pituitary; 2015 Oct; 18(5):710-21. PubMed ID: 25862551
[TBL] [Abstract][Full Text] [Related]
8. Increased expression of the microRNA 106b~25 cluster and its host gene MCM7 in corticotroph pituitary adenomas is associated with tumor invasion and Crooke's cell morphology.
Garbicz F; Mehlich D; Rak B; Sajjad E; Maksymowicz M; Paskal W; Zieliński G; Włodarski PK
Pituitary; 2017 Aug; 20(4):450-463. PubMed ID: 28432562
[TBL] [Abstract][Full Text] [Related]
9. Different micro-RNA expression profiles distinguish subtypes of neuroendocrine tumors of the lung: results of a profiling study.
Mairinger FD; Ting S; Werner R; Walter RF; Hager T; Vollbrecht C; Christoph D; Worm K; Mairinger T; Sheu-Grabellus SY; Theegarten D; Schmid KW; Wohlschlaeger J
Mod Pathol; 2014 Dec; 27(12):1632-40. PubMed ID: 24875640
[TBL] [Abstract][Full Text] [Related]
10. Tumor expression of miR-34a-3p is an independent predictor of recurrence in non-muscle-invasive bladder cancer and promising additional factor to improve predictive value of EORTC nomogram.
Juracek J; Stanik M; Vesela P; Radova L; Dolezel J; Svoboda M; Slaby O
Urol Oncol; 2019 Mar; 37(3):184.e1-184.e7. PubMed ID: 30446443
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-106b promotes pituitary tumor cell proliferation and invasion through PI3K/AKT signaling pathway by targeting PTEN.
Zhou K; Zhang T; Fan Y; Serick ; Du G; Wu P; Geng D
Tumour Biol; 2016 Oct; 37(10):13469-13477. PubMed ID: 27465551
[TBL] [Abstract][Full Text] [Related]
12. SDF-1α/MicroRNA-134 Axis Regulates Nonfunctioning Pituitary Neuroendocrine Tumor Growth
Wang X; Fang Y; Zhou Y; Guo X; Xu K; Li C; Zhang J; Hong Y
Front Endocrinol (Lausanne); 2020; 11():566761. PubMed ID: 33362712
[TBL] [Abstract][Full Text] [Related]
13. Next-generation sequencing of microRNAs reveals a unique expression pattern in different types of pituitary adenomas.
He Z; Chen L; Hu X; Tang J; He L; Hu J; Fei F; Wang Q
Endocr J; 2019 Aug; 66(8):709-722. PubMed ID: 31061247
[TBL] [Abstract][Full Text] [Related]
14. Global and Targeted miRNA Expression Profiling in Clear Cell Renal Cell Carcinoma Tissues Potentially Links miR-155-5p and miR-210-3p to both Tumorigenesis and Recurrence.
Zhang J; Ye Y; Chang DW; Lin SH; Huang M; Tannir NM; Matin S; Karam JA; Wood CG; Chen ZN; Wu X
Am J Pathol; 2018 Nov; 188(11):2487-2496. PubMed ID: 30201497
[TBL] [Abstract][Full Text] [Related]
15. MicroRNAs associated with small bowel neuroendocrine tumours and their metastases.
Miller HC; Frampton AE; Malczewska A; Ottaviani S; Stronach EA; Flora R; Kaemmerer D; Schwach G; Pfragner R; Faiz O; Kos-Kudła B; Hanna GB; Stebbing J; Castellano L; Frilling A
Endocr Relat Cancer; 2016 Sep; 23(9):711-26. PubMed ID: 27353039
[TBL] [Abstract][Full Text] [Related]
16. Case Report: Micro-RNAs in Plasma From Bilateral Inferior Petrosal Sinus Sampling and Peripheral Blood From Corticotroph Pituitary Neuroendocrine Tumors.
Niedra H; Peculis R; Konrade I; Balcere I; Romanovs M; Steina L; Stukens J; Sokolovska J; Klovins J; Rovite V
Front Endocrinol (Lausanne); 2022; 13():748152. PubMed ID: 35528014
[TBL] [Abstract][Full Text] [Related]
17. Lnc-SNHG1 Activates the TGFBR2/SMAD3 and RAB11A/Wnt/β-Catenin Pathway by Sponging MiR-302/372/373/520 in Invasive Pituitary Tumors.
Wang H; Wang G; Gao Y; Zhao C; Li X; Zhang F; Jiang C; Wu B
Cell Physiol Biochem; 2018; 48(3):1291-1303. PubMed ID: 30048990
[TBL] [Abstract][Full Text] [Related]
18. A MicroRNA cluster at 14q32 drives aggressive lung adenocarcinoma.
Nadal E; Zhong J; Lin J; Reddy RM; Ramnath N; Orringer MB; Chang AC; Beer DG; Chen G
Clin Cancer Res; 2014 Jun; 20(12):3107-17. PubMed ID: 24833665
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic and prognostic significance of miRNA signatures in tissues and plasma of endometrioid endometrial carcinoma patients.
Torres A; Torres K; Pesci A; Ceccaroni M; Paszkowski T; Cassandrini P; Zamboni G; Maciejewski R
Int J Cancer; 2013 Apr; 132(7):1633-45. PubMed ID: 22987275
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA expression in ovarian carcinoma and its correlation with clinicopathological features.
Lee H; Park CS; Deftereos G; Morihara J; Stern JE; Hawes SE; Swisher E; Kiviat NB; Feng Q
World J Surg Oncol; 2012 Aug; 10():174. PubMed ID: 22925189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
